Telo Genomics Corp (TELO) — Strategic Asset Allocation Index
Telo Genomics Corp (TELO) has a Strategic Asset Allocation Index of 5.7% as of March 2023. Strategic assets (PP&E of CA$46.89K plus long-term investments of CA$-) total CA$46.89K, measured against net assets of CA$815.81K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Telo Genomics Corp Strategic Asset Allocation Index (2015–2022)
This chart shows how Telo Genomics Corp's Strategic Asset Allocation Index has evolved across 6 annual periods from 2015 to 2022. As of March 2023, the index stands at 5.7%, representing strategic assets of CA$46.89K against net assets of CA$815.81K CAD. Explore TELO cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Telo Genomics Corp (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Telo Genomics Corp from 2015 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see TELO market cap overview.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.9% | CA$22.90K | CA$22.90K | CA$- | CA$2.60 Million | ▼ -0.8 pp |
| 2021 | 1.7% | CA$62.08K | CA$62.08K | CA$- | CA$3.69 Million | ▼ -13.1 pp |
| 2020 | 14.8% | CA$114.99K | CA$114.99K | CA$- | CA$775.25K | ▼ -6.1 pp |
| 2017 | 21.0% | CA$467.19K | CA$467.19K | CA$- | CA$2.23 Million | ▼ -0.9 pp |
| 2016 | 21.9% | CA$123.77K | CA$123.77K | CA$- | CA$566.45K | ▲ +20.8 pp |
| 2015 | 1.0% | CA$4.66K | CA$4.66K | CA$- | CA$449.24K | — |